Literature DB >> 6298220

Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.

T Salo, L A Liotta, K Tryggvason.   

Abstract

A type IV collagen-degrading enzyme activity secreted by a highly metastatic mouse tumor was purified by concanavalin A- and type IV collagen-agarose affinity chromatographies followed by gel filtration on Bio-Gel A-0.5 m. The apparent molecular weight of the enzyme was 160,000 but about 70,000 when Triton X-100 was added to the column buffer. The purified enzyme protein was resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis into two polypeptide chains of about 68,000 and 62,000 daltons. The enzyme activity could be increased by preincubation with trypsin and it is possible that the two chains represent latent and active enzyme forms. The enzyme activity was not reduced in the presence of dithiothreitol, it had a pH optimum of 7.6 and was inhibited by EDTA but not N-ethylmaleimide, phenylmethylsulfonyl fluoride, or Trasylol. The inhibition with EDTA was reversible. The pro-alpha 1(IV) and pro-alpha 2(IV) chains of the type IV procollagen substrate were both degraded at a similar rate to form two pairs of degradation fragments corresponding in molecular weights to about 70 and 30% of the original size chains. The presence of Triton X-100 increased slightly the activity of the enzyme and diminished the reduction of its activity upon freezing, indicating that the enzyme is a hydrophobic protein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298220

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.

Authors:  D H Lovett; R J Johnson; H P Marti; J Martin; M Davies; W G Couser
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Procollagenase activator produced by rabbit uterine cervical fibroblasts.

Authors:  M Ishibashi; A Ito; K Sakyo; Y Mori
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.

Authors:  T Kalebic; J E Williams; J E Talmadge; C S Kao-Shan; B Kravitz; K Locklear; G P Siegal; L A Liotta; M E Sobel; P S Steeg
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

5.  The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.

Authors:  M Davies; G J Thomas; J Martin; D H Lovett
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

6.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

Authors:  G I Goldberg; B L Marmer; G A Grant; A Z Eisen; S Wilhelm; C S He
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.

Authors:  Y Soini; P Pääkkö; H Autio-Harmainen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

Authors:  M Mohtai; R L Smith; D J Schurman; Y Tsuji; F M Torti; N I Hutchinson; W G Stetler-Stevenson; G I Goldberg
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 10.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.